News
The Food and Drug Administration is reconsidering its decision not to approve a drug that an Omaha mom says is saving her son ...
By Kingsley Webora TANKEH Bureaucratic bottlenecks and high regulatory costs at the Food and Drugs Authority (FDA) are discouraging many small- and medium-sized enterprises (SMEs) from obtaining the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results